Jordan2020-06-08T12:40:42+00:00Monday 8 Jun| Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer testing
Jordan2020-04-27T16:39:35+00:00Monday 27 Apr| Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines testing
Jordan2019-06-11T17:03:44+00:00Tuesday 11 Jun| Cystine–glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity testing
Jordan2019-04-26T18:56:56+00:00Friday 25 Jan| Fighting breast cancer stem cells through the immune-targeting of the xCT cystine-glutamate antiporter. testing
Jordan2019-04-26T18:51:00+00:00Tuesday 8 Jan| xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain testing
Jordan2019-04-26T18:46:34+00:00Thursday 6 Sep| xCT (SLC7A11)-mediated metabolic reprogramming promotes non- small cell lung cancer progression testing
Jordan2019-04-26T19:00:05+00:00Wednesday 6 Dec| A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo testing
Jordan2019-04-25T19:38:54+00:00Friday 25 Aug| The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate. testing
Jordan2019-04-29T20:03:49+00:00Wednesday 5 Apr| Poster > AX09: An Immunotherapy Candidate Targeting Breast Cancer Stem Cell Protein xCT testing
Jordan2019-04-29T15:12:42+00:00Monday 3 Oct| Poster > Development of a VLP-based RSV vaccine targeting pre-fusion F-protein testing
